Quantcast
Channel: Becker's Spine Review
Viewing all articles
Browse latest Browse all 24331

Argus raises Integra Lifesciences' price target to $61

$
0
0

Argus raised Integra Lifesciences' price objective from $55 to $61 in a research report, according to a Mideast Times report.


Viewing all articles
Browse latest Browse all 24331

Trending Articles